End-of-day quote
Shanghai S.E.
18:00:00 2024-04-25 EDT
|
5-day change
|
1st Jan Change
|
15.58
CNY
|
+3.11%
|
|
+7.89%
|
-8.78%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,694
|
5,581
|
5,423
|
12,759
|
13,738
|
12,008
|
Enterprise Value (EV)
1 |
4,002
|
4,850
|
4,267
|
11,646
|
10,419
|
8,585
|
P/E ratio
|
31
x
|
33
x
|
24.6
x
|
69.6
x
|
73.5
x
|
63.5
x
|
Yield
|
1.15%
|
0.48%
|
1.28%
|
0.42%
|
0.61%
|
0.76%
|
Capitalization / Revenue
|
4.92
x
|
5.68
x
|
4.79
x
|
11
x
|
12.3
x
|
9.71
x
|
EV / Revenue
|
4.19
x
|
4.94
x
|
3.77
x
|
10.1
x
|
9.29
x
|
6.94
x
|
EV / EBITDA
|
23.2
x
|
21
x
|
13.7
x
|
52.8
x
|
66.9
x
|
81.9
x
|
EV / FCF
|
184
x
|
10.9
x
|
13.1
x
|
100,061
x
|
138
x
|
123
x
|
FCF Yield
|
0.54%
|
9.14%
|
7.64%
|
0%
|
0.73%
|
0.81%
|
Price to Book
|
2.39
x
|
2.65
x
|
2.38
x
|
5.33
x
|
2.98
x
|
2.55
x
|
Nbr of stocks (in thousands)
|
540,816
|
540,816
|
535,878
|
535,878
|
703,061
|
703,061
|
Reference price
2 |
8.680
|
10.32
|
10.12
|
23.81
|
19.54
|
17.08
|
Announcement Date
|
19-04-26
|
20-04-28
|
21-04-28
|
22-04-22
|
23-04-18
|
24-03-22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
954.5
|
982.4
|
1,132
|
1,156
|
1,121
|
1,237
|
EBITDA
1 |
172.1
|
231.2
|
311.5
|
220.6
|
155.6
|
104.8
|
EBIT
1 |
134.8
|
192.4
|
273.4
|
186.7
|
124.9
|
79.06
|
Operating Margin
|
14.13%
|
19.58%
|
24.15%
|
16.15%
|
11.14%
|
6.39%
|
Earnings before Tax (EBT)
1 |
173.1
|
191.2
|
263.8
|
207.2
|
192.4
|
213.3
|
Net income
1 |
153.3
|
168.9
|
220.7
|
183.2
|
175.4
|
188.5
|
Net margin
|
16.06%
|
17.19%
|
19.5%
|
15.84%
|
15.64%
|
15.25%
|
EPS
2 |
0.2800
|
0.3130
|
0.4120
|
0.3420
|
0.2660
|
0.2690
|
Free Cash Flow
1 |
21.74
|
443.1
|
326.1
|
0.1164
|
75.56
|
69.89
|
FCF margin
|
2.28%
|
45.1%
|
28.81%
|
0.01%
|
6.74%
|
5.65%
|
FCF Conversion (EBITDA)
|
12.63%
|
191.66%
|
104.69%
|
0.05%
|
48.55%
|
66.7%
|
FCF Conversion (Net income)
|
14.18%
|
262.36%
|
147.78%
|
0.06%
|
43.09%
|
37.07%
|
Dividend per Share
2 |
0.1000
|
0.0500
|
0.1300
|
0.1000
|
0.1200
|
0.1300
|
Announcement Date
|
19-04-26
|
20-04-28
|
21-04-28
|
22-04-22
|
23-04-18
|
24-03-22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
693
|
731
|
1,156
|
1,113
|
3,319
|
3,424
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
21.7
|
443
|
326
|
0.12
|
75.6
|
69.9
|
ROE (net income / shareholders' equity)
|
7.61%
|
7.86%
|
9.57%
|
7.38%
|
4.77%
|
4%
|
ROA (Net income/ Total Assets)
|
3.54%
|
4.8%
|
6.3%
|
4.07%
|
1.92%
|
0.93%
|
Assets
1 |
4,332
|
3,515
|
3,504
|
4,503
|
9,140
|
20,336
|
Book Value Per Share
2 |
3.630
|
3.900
|
4.260
|
4.470
|
6.550
|
6.700
|
Cash Flow per Share
2 |
0.6500
|
0.9400
|
1.340
|
1.650
|
4.610
|
4.890
|
Capex
1 |
42.6
|
41.4
|
23.1
|
11.9
|
14
|
17.1
|
Capex / Sales
|
4.46%
|
4.22%
|
2.04%
|
1.02%
|
1.25%
|
1.38%
|
Announcement Date
|
19-04-26
|
20-04-28
|
21-04-28
|
22-04-22
|
23-04-18
|
24-03-22
|
|
1st Jan change
|
Capi.
|
---|
| -8.78% | 1.51B | | -5.77% | 14.68B | | -40.71% | 2.71B | | -12.92% | 2.44B | | -.--% | 1.12B | | +40.66% | 518M | | +91.79% | 502M | | +11.68% | 239M | | +1.67% | 183M | | -.--% | 168M |
Medical Imaging Systems
|